Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry

AIM: To detect the new serum biomarkers for colorectal cancer (CRC) by serum protein profiling with surfaceenhanced laser desorption ionisation - time of flight mass spectrometry (SELDI-TOF MS). METHODS: Two independent serum sample sets were analysed separately with the ProteinChip technology (set...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of gastroenterology : WJG 2006-03, Vol.12 (10), p.1536-1544
Hauptverfasser: Engwegen, Judith Y M N, Helgason, Helgi H, Cats, Annemieke, Harris, Nathan, Bonfrer, Johannes M G, Schellens, Jan H M, Beijnen, Jos H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1544
container_issue 10
container_start_page 1536
container_title World journal of gastroenterology : WJG
container_volume 12
creator Engwegen, Judith Y M N
Helgason, Helgi H
Cats, Annemieke
Harris, Nathan
Bonfrer, Johannes M G
Schellens, Jan H M
Beijnen, Jos H
description AIM: To detect the new serum biomarkers for colorectal cancer (CRC) by serum protein profiling with surfaceenhanced laser desorption ionisation - time of flight mass spectrometry (SELDI-TOF MS). METHODS: Two independent serum sample sets were analysed separately with the ProteinChip technology (set A: 40 CRC + 49 healthy controls; set B: 37 CRC + 31 healthy controls), using chips with a weak cation exchange moiety and buffer pH 5. Discriminative power of differentially expressed proteins was assessed with a classification tree algorithm. Sensitivities and specificities of the generated classification trees were obtained by blindly applying data from set A to the generated trees from set B and vice versa. CRC serum protein profiles were also compared with those from breast, ovarian, prostate, and non-small cell lung cancer. RESULTS: Mass-to-charge ratios (m/z) 3.1×10^3, 3.3× 10^3, 4.5×10^3, 6.6×10^3 and 28×10^3 were used as classitiers in the best-performing classification trees. Tree sensitivities and specificities were between 65% and 90%.Host of these discriminative m/z values were also different in the other tumour types investigated. M/z 3.3× 10^3, main classifier in most trees, was a doubly charged form of the 6.6× 10^3-Da protein. The latter was identified as apolipoprotein C-I. M/z 3.1×10^3 was identified as an N-terminal fragment of albumin, and m/z 28× 10^3 as apolipoprotein A-I. CONCLUSION: SELDI-TOF MS followed by classification tree pattern analysis is a suitable technique for finding new serum markers for CRC. Biomarkers can be identified and reproducibly detected in independent sample sets with high sensitivities and specificities. Although not specific for CRC, these biomarkers have a potential role in disease and treatment monitoring.
doi_str_mv 10.3748/wjg.v12.i10.1536
format Article
fullrecord <record><control><sourceid>wanfang_jour_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4124285</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>21590456</cqvip_id><wanfj_id>wjg200610007</wanfj_id><sourcerecordid>wjg200610007</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-5959d67efa378ab52050d473f956d3d5aa7db2f077c996184bcd8373dab50f4e3</originalsourceid><addsrcrecordid>eNpVUsuO1DAQjBCIHRbunJCFELcMjh3HyQVpteKx0kpc4Gw5fiQeHDtrJ7ua7-IH6eyMeBwsS-6q6m5XFcXrCu8pr9sPD4dhf1-RvYOHitHmSbEjpOpK0tb4abGrMOZlRwm_KF7kfMCYUMrI8-KiahjHtGa74teNNmFx1im5uBhQtCibtE5oTnExLmSkXVbJTS4AIAxIRR-TUYv0SMmgTEIzFEAjIxk0Go30y3gEWFhS9BmteWPlNVmpTGnCuJE08hLaIG1yTPNjYzguP85QLm4y2yDWu2Fc0CRzRnmGnilOZknHl8UzK302r873ZfHj86fv11_L229fbq6vbktVM7yUrGOdbrixkvJW9oxghnXNqe1Yo6lmUnLdE4s5V13XVG3dK91STjVgsa0NvSw-nnTntZ-MVrBkkl7M8BsyHUWUTvxfCW4UQ7wXdUVq0jIQeHcSeJDByjCIQ1xTgJEFGEcwbsAgzAH2_twnxbvV5EVM8OfGexlMXLNoeItbcAuA-ARUKeacjP0zS4XFFohNV0AgBARCbIEAypt_d_hLOCcAAG_PmmMMwx2YJXqpflrnjSAV63DNGvobmD_FVA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67808345</pqid></control><display><type>article</type><title>Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Engwegen, Judith Y M N ; Helgason, Helgi H ; Cats, Annemieke ; Harris, Nathan ; Bonfrer, Johannes M G ; Schellens, Jan H M ; Beijnen, Jos H</creator><creatorcontrib>Engwegen, Judith Y M N ; Helgason, Helgi H ; Cats, Annemieke ; Harris, Nathan ; Bonfrer, Johannes M G ; Schellens, Jan H M ; Beijnen, Jos H</creatorcontrib><description>AIM: To detect the new serum biomarkers for colorectal cancer (CRC) by serum protein profiling with surfaceenhanced laser desorption ionisation - time of flight mass spectrometry (SELDI-TOF MS). METHODS: Two independent serum sample sets were analysed separately with the ProteinChip technology (set A: 40 CRC + 49 healthy controls; set B: 37 CRC + 31 healthy controls), using chips with a weak cation exchange moiety and buffer pH 5. Discriminative power of differentially expressed proteins was assessed with a classification tree algorithm. Sensitivities and specificities of the generated classification trees were obtained by blindly applying data from set A to the generated trees from set B and vice versa. CRC serum protein profiles were also compared with those from breast, ovarian, prostate, and non-small cell lung cancer. RESULTS: Mass-to-charge ratios (m/z) 3.1×10^3, 3.3× 10^3, 4.5×10^3, 6.6×10^3 and 28×10^3 were used as classitiers in the best-performing classification trees. Tree sensitivities and specificities were between 65% and 90%.Host of these discriminative m/z values were also different in the other tumour types investigated. M/z 3.3× 10^3, main classifier in most trees, was a doubly charged form of the 6.6× 10^3-Da protein. The latter was identified as apolipoprotein C-I. M/z 3.1×10^3 was identified as an N-terminal fragment of albumin, and m/z 28× 10^3 as apolipoprotein A-I. CONCLUSION: SELDI-TOF MS followed by classification tree pattern analysis is a suitable technique for finding new serum markers for CRC. Biomarkers can be identified and reproducibly detected in independent sample sets with high sensitivities and specificities. Although not specific for CRC, these biomarkers have a potential role in disease and treatment monitoring.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v12.i10.1536</identifier><identifier>PMID: 16570345</identifier><language>eng</language><publisher>United States: Utrecht University, Faculty of Pharmaceutical Sciences, Department of Biomedical analysis,Utrecht, The Netherlands%Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands</publisher><subject>Algorithms ; Biomarkers, Tumor - blood ; Blood Proteins - analysis ; C-Reactive Protein - analysis ; Carcinoembryonic Antigen - blood ; Colorectal Cancer ; Colorectal Neoplasms - blood ; Colorectal Neoplasms - diagnosis ; Female ; Humans ; Male ; Protein Array Analysis - methods ; Sensitivity and Specificity ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods ; Transferrin - analysis ; 光谱测定 ; 检查方法 ; 结肠癌 ; 血清蛋白</subject><ispartof>World journal of gastroenterology : WJG, 2006-03, Vol.12 (10), p.1536-1544</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><rights>2006 Baishideng Publishing Group Co., Limited. All rights reserved. 2006</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-5959d67efa378ab52050d473f956d3d5aa7db2f077c996184bcd8373dab50f4e3</citedby><cites>FETCH-LOGICAL-c450t-5959d67efa378ab52050d473f956d3d5aa7db2f077c996184bcd8373dab50f4e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124285/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124285/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16570345$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Engwegen, Judith Y M N</creatorcontrib><creatorcontrib>Helgason, Helgi H</creatorcontrib><creatorcontrib>Cats, Annemieke</creatorcontrib><creatorcontrib>Harris, Nathan</creatorcontrib><creatorcontrib>Bonfrer, Johannes M G</creatorcontrib><creatorcontrib>Schellens, Jan H M</creatorcontrib><creatorcontrib>Beijnen, Jos H</creatorcontrib><title>Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>AIM: To detect the new serum biomarkers for colorectal cancer (CRC) by serum protein profiling with surfaceenhanced laser desorption ionisation - time of flight mass spectrometry (SELDI-TOF MS). METHODS: Two independent serum sample sets were analysed separately with the ProteinChip technology (set A: 40 CRC + 49 healthy controls; set B: 37 CRC + 31 healthy controls), using chips with a weak cation exchange moiety and buffer pH 5. Discriminative power of differentially expressed proteins was assessed with a classification tree algorithm. Sensitivities and specificities of the generated classification trees were obtained by blindly applying data from set A to the generated trees from set B and vice versa. CRC serum protein profiles were also compared with those from breast, ovarian, prostate, and non-small cell lung cancer. RESULTS: Mass-to-charge ratios (m/z) 3.1×10^3, 3.3× 10^3, 4.5×10^3, 6.6×10^3 and 28×10^3 were used as classitiers in the best-performing classification trees. Tree sensitivities and specificities were between 65% and 90%.Host of these discriminative m/z values were also different in the other tumour types investigated. M/z 3.3× 10^3, main classifier in most trees, was a doubly charged form of the 6.6× 10^3-Da protein. The latter was identified as apolipoprotein C-I. M/z 3.1×10^3 was identified as an N-terminal fragment of albumin, and m/z 28× 10^3 as apolipoprotein A-I. CONCLUSION: SELDI-TOF MS followed by classification tree pattern analysis is a suitable technique for finding new serum markers for CRC. Biomarkers can be identified and reproducibly detected in independent sample sets with high sensitivities and specificities. Although not specific for CRC, these biomarkers have a potential role in disease and treatment monitoring.</description><subject>Algorithms</subject><subject>Biomarkers, Tumor - blood</subject><subject>Blood Proteins - analysis</subject><subject>C-Reactive Protein - analysis</subject><subject>Carcinoembryonic Antigen - blood</subject><subject>Colorectal Cancer</subject><subject>Colorectal Neoplasms - blood</subject><subject>Colorectal Neoplasms - diagnosis</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Protein Array Analysis - methods</subject><subject>Sensitivity and Specificity</subject><subject>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods</subject><subject>Transferrin - analysis</subject><subject>光谱测定</subject><subject>检查方法</subject><subject>结肠癌</subject><subject>血清蛋白</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUsuO1DAQjBCIHRbunJCFELcMjh3HyQVpteKx0kpc4Gw5fiQeHDtrJ7ua7-IH6eyMeBwsS-6q6m5XFcXrCu8pr9sPD4dhf1-RvYOHitHmSbEjpOpK0tb4abGrMOZlRwm_KF7kfMCYUMrI8-KiahjHtGa74teNNmFx1im5uBhQtCibtE5oTnExLmSkXVbJTS4AIAxIRR-TUYv0SMmgTEIzFEAjIxk0Go30y3gEWFhS9BmteWPlNVmpTGnCuJE08hLaIG1yTPNjYzguP85QLm4y2yDWu2Fc0CRzRnmGnilOZknHl8UzK302r873ZfHj86fv11_L229fbq6vbktVM7yUrGOdbrixkvJW9oxghnXNqe1Yo6lmUnLdE4s5V13XVG3dK91STjVgsa0NvSw-nnTntZ-MVrBkkl7M8BsyHUWUTvxfCW4UQ7wXdUVq0jIQeHcSeJDByjCIQ1xTgJEFGEcwbsAgzAH2_twnxbvV5EVM8OfGexlMXLNoeItbcAuA-ARUKeacjP0zS4XFFohNV0AgBARCbIEAypt_d_hLOCcAAG_PmmMMwx2YJXqpflrnjSAV63DNGvobmD_FVA</recordid><startdate>20060314</startdate><enddate>20060314</enddate><creator>Engwegen, Judith Y M N</creator><creator>Helgason, Helgi H</creator><creator>Cats, Annemieke</creator><creator>Harris, Nathan</creator><creator>Bonfrer, Johannes M G</creator><creator>Schellens, Jan H M</creator><creator>Beijnen, Jos H</creator><general>Utrecht University, Faculty of Pharmaceutical Sciences, Department of Biomedical analysis,Utrecht, The Netherlands%Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands</general><general>Utrecht University, Faculty of Pharmaceutical Sciences, Department of Biomedical analysis,Utrecht, The Netherlands</general><general>Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands%Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands%Department of Gastroenterology and Hepatology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands%Ciphergen Biosystems Inc., Freemont, California, United States%Department of Clinical Chemistry, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital,Amsterdam, The Netherlands%Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands</general><general>Baishideng Publishing Group Co., Limited</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope><scope>5PM</scope></search><sort><creationdate>20060314</creationdate><title>Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry</title><author>Engwegen, Judith Y M N ; Helgason, Helgi H ; Cats, Annemieke ; Harris, Nathan ; Bonfrer, Johannes M G ; Schellens, Jan H M ; Beijnen, Jos H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-5959d67efa378ab52050d473f956d3d5aa7db2f077c996184bcd8373dab50f4e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Algorithms</topic><topic>Biomarkers, Tumor - blood</topic><topic>Blood Proteins - analysis</topic><topic>C-Reactive Protein - analysis</topic><topic>Carcinoembryonic Antigen - blood</topic><topic>Colorectal Cancer</topic><topic>Colorectal Neoplasms - blood</topic><topic>Colorectal Neoplasms - diagnosis</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Protein Array Analysis - methods</topic><topic>Sensitivity and Specificity</topic><topic>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods</topic><topic>Transferrin - analysis</topic><topic>光谱测定</topic><topic>检查方法</topic><topic>结肠癌</topic><topic>血清蛋白</topic><toplevel>online_resources</toplevel><creatorcontrib>Engwegen, Judith Y M N</creatorcontrib><creatorcontrib>Helgason, Helgi H</creatorcontrib><creatorcontrib>Cats, Annemieke</creatorcontrib><creatorcontrib>Harris, Nathan</creatorcontrib><creatorcontrib>Bonfrer, Johannes M G</creatorcontrib><creatorcontrib>Schellens, Jan H M</creatorcontrib><creatorcontrib>Beijnen, Jos H</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Engwegen, Judith Y M N</au><au>Helgason, Helgi H</au><au>Cats, Annemieke</au><au>Harris, Nathan</au><au>Bonfrer, Johannes M G</au><au>Schellens, Jan H M</au><au>Beijnen, Jos H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2006-03-14</date><risdate>2006</risdate><volume>12</volume><issue>10</issue><spage>1536</spage><epage>1544</epage><pages>1536-1544</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>AIM: To detect the new serum biomarkers for colorectal cancer (CRC) by serum protein profiling with surfaceenhanced laser desorption ionisation - time of flight mass spectrometry (SELDI-TOF MS). METHODS: Two independent serum sample sets were analysed separately with the ProteinChip technology (set A: 40 CRC + 49 healthy controls; set B: 37 CRC + 31 healthy controls), using chips with a weak cation exchange moiety and buffer pH 5. Discriminative power of differentially expressed proteins was assessed with a classification tree algorithm. Sensitivities and specificities of the generated classification trees were obtained by blindly applying data from set A to the generated trees from set B and vice versa. CRC serum protein profiles were also compared with those from breast, ovarian, prostate, and non-small cell lung cancer. RESULTS: Mass-to-charge ratios (m/z) 3.1×10^3, 3.3× 10^3, 4.5×10^3, 6.6×10^3 and 28×10^3 were used as classitiers in the best-performing classification trees. Tree sensitivities and specificities were between 65% and 90%.Host of these discriminative m/z values were also different in the other tumour types investigated. M/z 3.3× 10^3, main classifier in most trees, was a doubly charged form of the 6.6× 10^3-Da protein. The latter was identified as apolipoprotein C-I. M/z 3.1×10^3 was identified as an N-terminal fragment of albumin, and m/z 28× 10^3 as apolipoprotein A-I. CONCLUSION: SELDI-TOF MS followed by classification tree pattern analysis is a suitable technique for finding new serum markers for CRC. Biomarkers can be identified and reproducibly detected in independent sample sets with high sensitivities and specificities. Although not specific for CRC, these biomarkers have a potential role in disease and treatment monitoring.</abstract><cop>United States</cop><pub>Utrecht University, Faculty of Pharmaceutical Sciences, Department of Biomedical analysis,Utrecht, The Netherlands%Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands</pub><pmid>16570345</pmid><doi>10.3748/wjg.v12.i10.1536</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2006-03, Vol.12 (10), p.1536-1544
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4124285
source MEDLINE; PubMed Central; Alma/SFX Local Collection
subjects Algorithms
Biomarkers, Tumor - blood
Blood Proteins - analysis
C-Reactive Protein - analysis
Carcinoembryonic Antigen - blood
Colorectal Cancer
Colorectal Neoplasms - blood
Colorectal Neoplasms - diagnosis
Female
Humans
Male
Protein Array Analysis - methods
Sensitivity and Specificity
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods
Transferrin - analysis
光谱测定
检查方法
结肠癌
血清蛋白
title Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T09%3A12%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20serum%20proteins%20discriminating%20colorectal%20cancer%20patients%20and%20healthy%20controls%20using%20surface-enhanced%20laser%20desorption%20ionisation-time%20of%20flight%20mass%20spectrometry&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Engwegen,%20Judith%20Y%20M%20N&rft.date=2006-03-14&rft.volume=12&rft.issue=10&rft.spage=1536&rft.epage=1544&rft.pages=1536-1544&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v12.i10.1536&rft_dat=%3Cwanfang_jour_pubme%3Ewjg200610007%3C/wanfang_jour_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67808345&rft_id=info:pmid/16570345&rft_cqvip_id=21590456&rft_wanfj_id=wjg200610007&rfr_iscdi=true